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Abstract
Group B Streptococcus (GBS) was the main causative organism of
invasive infections in newborns due to vertical transmission from
the colonized mothers. The study was undertaken to determine
colonization rate, serotype distribution, genotypic characteriza-
tion, antibiotic susceptibility proﬁles and molecular characteris-
tics of erythromycin-resistant strains of GBS in pregnant women
in Beijing, China. Vaginal–rectal swabs were collected from a
total of 2850 pregnant women at 35–37 weeks of gestation, in
which 7.1% were GBS positive. Serotypes III, Ia and V predom-
inated. All isolates were penicillin susceptible, whereas the
resistance rates for erythromycin and clindamycin were strikingly
high.
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Group B streptococcus (GBS) is asymptomatically colonized in
the vagina and rectum of 10–30% of pregnant women [1]. It is
estimated that 50.0% of newborns, if exposed to GBS during
delivery, will be colonized, 2.0% of whom will develop an
invasive infection [1]. Routine screening for maternal coloni-
zation by GBS has been performed for prevention of neonatal
infections [1,2]. For a better understanding of the genetic
variability of GBS in Beijing, China, we undertook to investigate
its epidemiological characterization in pregnant women, which
has been was rarely reported.
A total of 2850 pregnant women at 35–37 weeks of
gestation, aged 19–42 years (mean age 29.5  3.6, 11.9% aged
over 35), were entered into the study. They received routine
prenatal care consecutively at Civil Aviation General Hospital,
a 550-bed tertiary teaching medical centre in Beijing, from
September 2011 to February 2013. Their vaginal–rectal
specimens were collected with solid-shaft, nylon-tipped
ﬂocked swabs and processed as recommended previously
[1]. The Institutional Review Boards at the Civil Aviation
General Hospital approved the study protocol. Colonies on
blood agar plates were identiﬁed using Gram staining, cAMP
test and the Vitek-2 microbiology system (bioMerieux, Marcy
l’Etoile, France).
The ten GBS serotypes (Ia, Ib, II–IX) based on capsular
polysaccharide (cps) were distinguished mainly using PCR
methods developed previously [3–5]. The isolate was deﬁned
as non-typeable if the PCR methods failed to identify it into any
serotype. Multilocus sequence typing was conducted by
sequencing seven housekeeping genes using the database
(http://pubmlst.org/sagalactiae) [6]. Burst analysis was con-
ducted to analyse clonal complexes (CCs) using the EBURST
V3 version (http://eburst.mlst.net). Each CC was deﬁned to
have at least three different sequence types (STs). The ST not
included in any cluster was classiﬁed as singleton. BIONUMERICS
software version 5.1 (Applied Maths, Kortrijk, Belgium) was
used to create a minimum spanning tree.
All isolates were tested for susceptibility to penicillin G,
ampicillin, erythromycin, clindamycin and vancomycin (Oxoid,
Basingstoke, UK) using a disc diffusion method [7]. The strains
resistant to clindamycin or macrolide were conﬁrmed by
Phoenix 100 Automated Microbiology System SMIC/ID-2 panel
(Becton Dickinson, Franklin Lakes, NJ). The macrolide-resistant
isolates were further classiﬁed as having the cMLSB (constitutive
macrolide-lincosamide-streptogramin B resistance), iMLSB
(inducible resistance), or M phenotype (macrolide-streptogr-
amin B resistance and lincosamide susceptibility) by a dou-
ble-disc test as described elsewhere [7,8]. The ermB, ermA
(subclass ermTR), and mefA/E genes from the macrolide-resis-
tant isolates, and the linB gene in the strains resistant to
clindamycin but susceptible to erythromycin (L phenotype),
were ampliﬁed using previously described primers [9,10].
The current study demonstrated a low maternal GBS
carriage rate (7.1%) in Beijing, China. Serotype III was the most
prevalent serotype, followed by Ia, V, Ib and II. Neither VII nor
IX was detected (Table 1). Only one isolate was non-typeable,
similar to the previous reports [3,11].
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A total of 28 individual STs were distinguished, and 82.6% of
isolates were represented by seven main STs. Two novel STs
designated as ST623 and ST624 were the single-locus variants
of ST485 and ST23, respectively. Twenty STs, representing
92.5% of the isolates, were clustered into ﬁve CCs (Fig. 1).
All GBS isolates were susceptible to penicillin, ampicillin and
vancomycin. They were frequently resistant to clindamycin
(55.7%) and erythromycin (66.2%). The erythromycin-resis-
tance was mainly associated with the ermB genes, as detected
in 44.4% erythromycin-resistant isolates, with only 23.3 and
22.6% harbouring the ermTR and mefA/E genes, respectively.
No isolates were found to carry ermTR and ermB, or ermTR
and mefA/E at the same time.
The GBS colonized rate in the current study was generally
lower than that in the USA and Africa [1,11], but comparable
to that in Asia: 8.2 or 16% in Japan, 7.5% in the Philippines
(Manila) and 8.0% in Korea [11]. The serodistribution of GBS
showed the characteristics similar to those described world-
wide [11], but the prevalence of III was as high as 41.8%, only
comparable to that in a Korean study (43.8%) [12]. VI (24.7%)
and VIII (35.6%) were reported to predominate among
Japanese pregnant women [13], but were less prevalent in
their Chinese counterpart.
Multilocus sequence typing allowed the comparison of
genetic proﬁles of isolates recovered from various geographic
areas. In our study, the prevalence of ST17 was as low as 6.0%.
It was suggested that, compared with cps III ST19 strains, ST17
isolates had unique characteristics independent of cps type that
contribute to more invasive diseases [14]. The hypervirulence
of ST17 might be explained by the expression of a newly
identiﬁed ST17-speciﬁc surface-anchored protein, named as
hypervirulent GBS adhesin (HvgA) [15].
The main CCs in our study were also highly prevalent in
other regions [11,14]. Most CC17 strains were cps III.
Interestingly a strain of cps II and ST64 was found to belong
to the CC17 in our study. It was reported that three strains of
CC17 were cps IV [16]. This capsular switching was due to the
replacement of cps type III by the cps type IV in the ST17
genetic background [16].
GBS isolates with reduced penicillin susceptibility have been
reported in Japan [17] and Hong Kong [18], but this was not
observed in our study. For women allergic to b-lactams,
erythromycin and clindamycin were recommended as antibiotic
alternatives [1]; however, recent reports had raised global
concerns about their increasing resistance rates in GBS
[8,12,19]. The rates of resistance to clindamycin and erythro-
mycin reported here were higher than those in Korea (54.0% to
clindamycin and 25.6% to erythromycin) [12] and the USA
(38.4% to clindamycin and 50.7% to erythromycin) [8]. This
emphasized the universal implementation of the 2010 guideline
recommending that GBS isolates be tested for antibiotic
resistance before initiating prophylaxis with erythromycin and
clindamycin [1]. The resistance to macrolides in GBS strains is
commonly mediated by two mechanisms: methylation of 23S
ribosomal RNA, encoded mainly by ermB and ermA (subclass
ermTR) genes, and active drug efﬂux by pumps determined by
mefA/E genes. In the current study, ermB was the principal
erythromycin-resistant gene (44.4%), with a prevalence almost
TABLE 1. Correlation between clonal complexes, serotypes and macrolide-resistance phenotypes and genotypes of 201 Group B
streptococcus in Beijing, China
No. of total
strains CC1 (%) CC19 (%) CC17 (%) CC23 (%) CC12 (%)
Singletons (%)
(ST4, 24, 26, 46, 459,
485, 498, and 623)
No. of strains (%)a 201 28 (13.9) 75 (37.4) 15 (7.5) 33 (16.4) 35 (17.5) 15 (7.5)
Serotype (No.)
Ia 43 (21.4) 2 (1.0) 3 (1.5) – 27 (13.4) 2 (1.0) 9 (4.5)
Ib 24 (11.9) 1 (0.5) – – – 23 (11.4) –
II 14 (7.0) 5 (2.5) 4 (2.0) 1 (0.5) 1 (0.5) 3 (1.5) –
III 84 (41.8) 1 (0.5) 63 (31.3) 14 (7.0) 3 (1.5) – 3 (1.5)
IV 1 (0.5) – – – – – 1 (0.5)
V 30 (14.9) 15 (7.5) 5 (2.5) – 2 (1.0) 6 (3.0) 2 (1.0)
VI 3 (1.5) 3 (1.5) – – – – –
VIII 1 (0.5) – – – – 1 (0.5) –
NT 1 (0.5) 1 (0.5) – – – – –
Macrolide-resistance phenotype
M phenotype 30 (14.9) 1 (0.5) 20 (10.0) – 5 (2.5) 3 (1.5) 1 (0.5)
cMLSB 87 (43.3) 15 (7.5) 23 (11.4) 10 (5.0) 6 (3.0) 22 (10.9) 11 (5.5)
iMLSB 16 (8.0) 6 (3.0) 6 (3.0) 1 (0.5) 3 (1.5) – –
Macrolide-resistance genotype
ermB 59 (29.4) 12 (6.0) 20 (10.0) 5 (2.5) 5 (2.5) 12 (6.0) 5 (2.5)
ermTR 31 (15.4) 4 (2.0) 7 (3.5) 5 (2.5) 2 (1.0) 10 (5.0) 3 (1.5)
ermB+mefA/E 2 (1.0) – – – 2 (1.0) – –
mefA/E 30 (14.9) 1 (0.5) 20 (10.0) – 5 (2.5) 3 (1.5) 1 (0.5)
Negative 11 (5.5) 5 (2.5) 2 (1.0) 1 (0.5) – – 3 (1.5)
aPercentage in parentheses represents isolates/total GBS isolates (201).
CC, clonal complexes; NT, non-typeable strains; cMLSBB, constitutive macrolide-lincosamide-streptogramin B resistance; iMLSBB, inducible macrolide-lincosamide-streptogramin
B resistance; M Phenotype, macrolide-streptogramin B resistance and lincosamide susceptibility.
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twice that of ermTR and mefA/E genes, respectively, which is
different from the reports fromother countries [10,19]. The linB
gene encodes a lincosamide nucleotidyltransferase and confers
the L phenotype. In our study, 4.5% (9/201) GBS strains were
identiﬁed as L phenotype, of which ﬁve isolates carried the linB
gene, occurred much less frequently than in Korea, where 46L
phenotypes were found in 371 isolates, and 43 (94%) carried the
linB gene [20]. However, only one strain was observed to carry
linB gene in 6L phenotypes in a total of 222 GBS isolates in New
Jersey, USA [9]. This demonstrated that the prevalence rates of
the L phenotype and linB gene in GBS varied between regions.
In summary, our data showed the epidemiological charac-
teristics of GBS in Beijing: the low colonization rate, the high
prevalence of serotype III, and the increased clindamycin and
erythromycin resistance rates. The study will contribute to the
development of a screening-based strategy to prevent GBS
neonatal infections in China.
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